Stocklytics Platform
Asset logo for symbol BEATW
HeartBeam
BEATW4
$0.75arrow_drop_up2.66%$0.02
Penny Stock
Asset logo for symbol BEATW
BEATW4

$0.75

arrow_drop_up2.66%

Performance History

Chart placeholder
Key Stats
Open$0.75
Prev. Close$0.75
EPS-0.49
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$0.00
PE Ratio-
LOWHIGH
Day Range0.75
0.75
52 Week Range0.14
1.23
Ratios
Revenue-
EBITDA Margin %-
EPS-0.49

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About HeartBeam (BEATW)

HeartBeam, Inc. (BEATW) is a leading medical technology company that specializes in the development and manufacturing of innovative healthcare devices. The company's primary focus is on cardiac monitoring and imaging systems, which are used by healthcare professionals to diagnose and treat various heart conditions. With a strong commitment to research and development, HeartBeam has been able to consistently introduce groundbreaking products that revolutionize the field of cardiology. The company's flagship product, the HeartBeam Monitor, is a state-of-the-art device that allows for real-time monitoring of patients' heart activity. It utilizes advanced sensors and algorithms to provide accurate and reliable data, enabling physicians to make informed decisions about patient care. The HeartBeam Monitor has been widely praised for its user-friendly interface, high-quality imaging, and long battery life. It has quickly become the gold standard in cardiac monitoring and has garnered a large market share in the industry.
In addition to its innovative product portfolio, HeartBeam, Inc. has also made significant investments in research and development to stay at the forefront of technological advancements in the field. The company's team of scientists and engineers are constantly exploring new ways to improve the accuracy and efficiency of their devices, ensuring that healthcare professionals have access to the most advanced tools available. Furthermore, HeartBeam actively collaborates with renowned medical institutions and professionals to gain insights and feedback that help shape the future direction of their products. This collaborative approach has led to a continuous stream of innovations that set HeartBeam apart from its competitors.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add HeartBeam to watchlist

Keep an eye on HeartBeam

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is HeartBeam's (BEATW) price per share?

The current price per share for HeartBeam (BEATW) is $0.75. The stock has seen a price change of $0.02 recently, indicating a 2.67% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for HeartBeam (BEATW)?

For HeartBeam (BEATW), the 52-week high is $1.23, which is 64% from the current price. The 52-week low is $0.14, the current price is 435.71% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is HeartBeam (BEATW) a growth stock?

HeartBeam (BEATW) has shown an average price growth of -4.13% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying HeartBeam as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is HeartBeam (BEATW) stock price performance year to date (YTD)?

As of the latest data, HeartBeam (BEATW) has a year-to-date price change of 139.01%. Over the past month, the stock has experienced a price change of 7.14%. Over the last three months, the change has been 63.04%. Over the past six months, the figure is 47.06%.
help

Is HeartBeam (BEATW) a profitable company?

HeartBeam (BEATW) has a net income of -$14.64M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$15.31M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of HeartBeam (BEATW)?

HeartBeam (BEATW) has a market capitalization of $0. The average daily trading volume is 0.75, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level